Abstract
Pancreatic ductal adenocarcinoma (PDAC) has an 8.5% 5-year survival rate. Early detection, increasing use of neoadjuvant therapy and the opportunity for oncologic surgery is the best chance for cure. EUS is considered to be the superior imaging modality to detect small (<20mm) PDAC lesions and their precursors. We aimed to identify suspect lesions on EUS performed before the eventual diagnosis of PDAC.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
